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Imaging and Diagnostic TestingDevelopment of tricuspid regurgitation late after
left-sided valve surgery: A single-center experience
with long-term echocardiographic examinations
Jae-Jin Kwak, MD,a Yong-Jin Kim, MD,a Min-Kyung Kim, MD,a Hyung-Kwan Kim, MD,a Jin-Shik Park, MD,a
Kyung-Hwan Kim, MD,b Ki-Bong Kim, MD,b Hyuk Ahn, MD,b Dae-Won Sohn, MD, FACC,a
Byung-Hee Oh, MD, FACC,a and Young-Bae Park, MDa Seoul, South KoreaObjectives This study sought to investigate the incidence and identify the predictors of significant tricuspid regurgitation
(TR) development long after left-sided valve surgery.
Methods Of 615 patients who underwent surgery for left-sided valve disease between 1992 and 1995, 335 patients
without significant TR who completed at least 5 years of clinical and echocardiographic follow-up were enrolled. Late
significant TR development was assessed by echocardiography with a mean follow-up duration of 11.6 ± 2.1 years.
Results Significant late TR was found in 90 patients (26.9%). Patients with late TR showed an advanced age (47.6 ±
13.4 vs 44.3 ± 13.2 years, P = .04), a higher prevalence of preoperative atrial fibrillation (83.3 vs 46.5%, P b .001), a
greater left atrial dimension (56.9 ± 13.2 vs 52.4 ± 11.5mm, P = .006), and a higher prevalence of prior valve surgery
(40.0 vs 25.3%, P = .01). In addition, late TR occurred more frequently in patients who had undergone mitral valve surgery
than in those who did not (93.3 vs 72.2%, P b .001). However, multivariate analysis showed that the presence of
preoperative atrial fibrillation (odds ratio 5.37; 95% CI 2.71-10.65; P b .001) was the only independent factor of late TR
development. Patients who developed late TR had a lower event-free survival rate than those who did not (P = .03).
Conclusions The development of significant TR long after left-sided valve surgery is not uncommon with an estimated
incidence of 27% and is closely associated with a poor prognosis. The presence of preoperative atrial fibrillation was
identified as the only independent predictor of the development of late TR. (Am Heart J 2008;155:732-7.)Tricuspid regurgitation (TR) is a common finding in
patients undergoing mitral or combined mitral/aortic
valve surgery.1,2 Although TRmay decrease gradually after
left-sided valve surgery owing to reduced right ventricular
pressure or volume overload,3 TR does not always regress
after adequate correction of the underlying lesions 4,5 and
often progresses some time after surgery without left-
sided valvular dysfunction, even after tricuspid annulo-
plasty. Furthermore, TR can appear de novo during
postoperative follow-up. Because it is well known that TR
progression badly affects long-term mortality and mor-
bidity, and that surgical correction of TR after left-sided
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mortality and morbidity,6-9 the prevention of late TR is
clinically important. In this regard, information regarding
the incidence and predictors of progression or develop-
ment of late TR is of substantial value for determining
optimal operative timing and the surgical strategy to
prevent late TR development, at the time of surgery for
underlying left-sided valve disease. Several previous
reports on this topic have been limited by a relatively small
study population,5,10 a short-term follow-up,11 or the lack
of reliable echocardiographic data.12 Therefore, the
present study was performed to investigate the incidence
of late de novo TR development after left-sided valve
surgery and to identify preoperative predictors in patients
without significant preoperative TR by long-term clinical
and echocardiographic follow-up.Methods
Study population
This study was based on our consecutive experiences of
patients who underwent surgical correction for left-sided valve
disease from January 1992 to December 1995. During this
period, a total of 615 patients underwent surgery for mitral,
aortic, or combined mitral/aortic valve disease at our institution,
Table I. Baseline characteristics of the study subjects
Characteristics n (%)
Sex (male) 159 (47.5)
Age (y) 45.2 ± 13.3 (range 16-81)
BMI (kg/m2) 21.4 ± 2.8 (range 14.5-29.4)
Duration of follow-up (y) 11.6 ± 2.1 (range 61-175)
Preoperative electrocardiography
Sinus rhythm 146 (43.6)
Atrial fibrillation 189 (56.4)
Preoperative echocardiography
LV Ejection fraction (%) 60.1 ± 12.6 (range 20-89)
LV end-diastolic diameter (mm) 57.3 ± 11.9 (range 35-100)




42.9 ± 18.6 (range 8-140)
Pulmonary capillary wedge
pressure (mm Hg)
20.0 ± 8.8 (range 3-50)
Mean right atrial pressure (mm Hg) 5.8 ± 4.0 (range 1-18)
BMI, Body mass index; LV, left ventricle.
Table II. Underlying valve diseases at time of surgery
AV diseases
TotaNormal AS AR ASR
MV diseases Normal 0 18 30 16 64
MS 50 2 16 12 80
MR 62 3 36 8 109
MSR 46 2 16 18 82
Total 158 25 98 54 335
MV, Mitral valve;MR, mitral regurgitation;MS, mitral stenosis;MSR, combined mitra
stenosis and regurgitation; AV, aortic valve; AS, aortic stenosis; AR, aorti
regurgitation; ASR, combined aortic stenosis and regurgitation.
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However, we excluded patients who underwent combined
tricuspid valve replacement (n = 19), aortic surgery (n = 20),
correction of combined congenital anomaly (n = 31), and
coronary artery bypass graft surgery (n = 22). Seventy-four
patients who were lost to follow-up, 40 patients who died
within 5 years of index surgery, and 74 patients with significant
preoperative TR, moderate or severe in degree, were also
excluded. Accordingly, 335 patients (159 male, 47.5%) who
completed at least a 5-year clinical and echocardiographic
follow-up were enrolled.
Baseline data procurement
Patient hospital records and our cardiac surgery database
were reviewed for the following: age at index surgery, sex, body
weight, height, heart rhythm, type of surgery, and history of
prior cardiac surgery. Preoperative cardiac catheterization was
performed in all patients, and parameters including pulmonary
capillary wedge pressure, systolic pulmonary artery pressure,
and mean right atrial pressure were measured. A preoperative
echocardiographic examination was performed in all patients by
a skilled echocardiographer and interpreted by an experienced
cardiologist. Left ventricular end-systolic and end-diastolic
diameters, left ventricular ejection fraction, left atrial dimension,
and valvular functions were comprehensively evaluated.
Etiologies of valvular disease were confirmed based on surgical
observations and/or pathologic findings. The study protocol was
approved by the Institutional Review Board of Seoul National
University Hospital.
Echocardiographic examinations
Comprehensive 2-dimensional and Doppler echocardio-
graphic examinations were performed preoperatively and
repeated after discharge from hospital by skilled echocardio-
graphers in a standard manner using commercially available
echocardiographic devices. The presence of TR and its severity
were assessed using multiple transthoracic windows. The
maximal TR jet area in any echocardiographic view was used to
semi-quantitatively estimate TR grade using a standard colorl
l
c
Doppler technique. Tricuspid regurgitation grade was classified
as none, trace, mild, moderate, or severe in each patient.13,14 To
simplify statistical analysis, significant TR was defined as
moderate or severe in degree. Maximal TR jet velocity was
obtained by continuous-wave Doppler and was used to calculate
systolic pulmonary artery pressure. Latest echocardiographic
examinations were regarded as the end of the follow-up period.
Statistical analysis
Continuous variables are expressed as means ± SD, and
categorical variables as percentages. Multiple logistic regression
analysis using the forward stepwise selection process, including
all significant parameters identified by univariate analysis and
previously known confounding variables, was undertaken to
identify parameters independently associated with the presence
of significant TR after surgery. Event-free cumulative survival
rates were plotted using the Kaplan-Meier method and
comparisons were made between patient groups with and
without late significant TR using the log-rank test. SPSS 13.0
(SPSS Inc, Chicago, IL) was used for the statistical analyses and
P values of b.05 were considered statistically significant.
Results
Baseline characteristics
The baseline characteristics of the 335 study subjects
are summarized in Table I. Mean follow-up duration was
11.6 ± 2.1 years (range 5.1-14.6 years). Preoperative
electrocardiograms showed atrial fibrillation in 189
(56.4%) of the patients.
Mitral valve surgery (mitral valve replacement or mitral
valve repair) without accompanying aortic valve surgery
was performed in 174 patients (51.9%), aortic valve
surgery alone (aortic valve replacement or aortic valve
repair) in 74 (22.1%), and combined mitral and aortic
valve surgery in the remaining 87 (26.0%). At the time of
left-sided valve surgery, tricuspid annuloplasty was
performed in 15 patients (4.5%).
Preoperative diagnoses according to valve disease and
the procedures performed to correct underlying valve
abnormalities are detailed in Tables II and III, respectively.
Of 261 patients who underwent mitral valve surgery with
or without an aortic valve operation, mitral valve diseases
were caused by rheumatic disease in 138 (52.9%),







MV surgery MVR 77 1 133 211
MV repair 7 2 41 50
Without MV
surgery
69 5 0 74
Total 153 8 174 335
MVR, Mitral valve replacement; AVR, aortic valve replacement.
Figure 1
Development of significant TR during follow-up after left-sided valve
surgery in all study subjects, and in patients according to cardiac
rhythm. Af, Atrial fibrillation.
Table IV. Main clinical and echocardiographic characteristics
according to the presence of significant late TR
Characteristics
Late TR (+) ⁎
(n = 90)
Late TR (−)
(n = 245) P Value
Age (y) 47.6 ± 13.4 44.3 ± 13.2 .04
Male/female 38:52 121:124 .24
BMI (kg/m2) 21.3 ± 2.6 21.5 ± 2.9 .63
MV/non-MV surgery 84:6 177:68 b.001
Previous valve surgery 36 (40.0%) 62 (25.3%) .009
Preoperative AF 75 (83.3%) 114 (46.5%) b.001
Preoperative
echocardiographic data
LVEF (%) 60.1 ± 13.0 60.0 ± 12.5 .98
LVEDD (mm) 54.6 ± 11.1 58.4 ± 12.0 .01
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LA size (mm) 56.9 ± 13.2 52.4 ± 11.5 .006
Preoperative cardiac
catheterization data
PASP (mm Hg) 44.6 ± 16.9 42.2 ± 19.2 .34
PCWP (mm Hg) 20.8 ± 8.9 19.7 ± 8.7 .36
mRAP (mm Hg) 5.8 ± 3.8 5.9 ± 4.0 .94
⁎Significant late TR was defined as moderate or severe in degree.AF, Atrial fibrillation;
LVEF, left ventricular ejection fraction; LVEDD, left ventricular end-diastolic dimension;
LA, left atrium; PASP, pulmonary artery systolic pressure; PCWP, pulmonary capillary
wedge pressure; mRAP, mean right atrial pressure.prosthetic valve failure in 77 (29.5%), mitral valve
prolapse in 26 (10.0%), and others (including endocardi-
tis and congenital disease) in 19 (7.3%). On the other
hand, of the 161 patients who underwent aortic valve
surgery with or without a mitral valve operation,
degenerative disease was the most common etiology for
aortic valve surgery (49 patients, 30.4%), followed by
rheumatic disease in 46 (28.6%), prosthetic valve failure
in 33 (20.5%), and others (including congenital disease
and endocarditis) in 33 (20.5%).
Development of late significant TR
The development of late significant TR in all study
subjects and patients according to cardiac rhythm is shown
in Figure 1. Significant TR had developed in 90 patients
(26.9%) at last follow-ups, and this was severe in 25 (7.5%).
Clinical and echocardiographic characteristics accord-
ing to the presence or absence of late TR are summarized
in Table IV. Patients who developed late TR were older
(47.6 ± 13.4 vs 44.3 ± 13.2 years, P = .04), had a higher
prevalence of preoperative atrial fibrillation (83.3% vs
46.5%, χ2 = 36.3, P b .001), a greater left atrial dimension
(56.9 ± 12.3 vs 52.4 ± 11.5 mm, P = .006), a lower leftventricular end-diastolic dimension (54.6 ± 11.1 vs 58.4 ±
12.0 mm, P = .01), and were more likely to have
undergone prior valve surgery (44.0% vs 25.3%, χ2 = 6.9,
P = .009). Of note, late TR was observed more frequently
in patients with mitral valve surgery (93.3% vs 72.2%, χ2 =
17.0, P b .001). However, other factors, such as
etiologies, left ventricular ejection fraction, systolic
pulmonary artery pressure, pulmonary capillary wedge
pressure, and mean right atrial pressure, were compar-
able in the 2 study groups.
Independent determinants of late TR
To identify independent clinical and echocardiographic
factors for the development of late TR, we performed
multivariate forward conditional logistic regression ana-
lysis using clinical, echocardiographic, and cardiac
catheterization parameters, that is, age, sex, history of
previous valve surgery, performance of mitral valve
surgery, presence of preoperative atrial fibrillation, left
atrial size, left ventricular end-diastolic dimension,
preoperative systolic pulmonary artery pressure, and
presence of preoperative mild TR. This analysis identified
the presence of preoperative atrial fibrillation (odds ratio
5.37, 95% CI 2.71-10.65, P b .001) as the only
independent determinant of the development of late TR.
Clinical events during follow-up
Of the 335 study subjects, 62 patients succumbed
away during follow-up. Causes of death were heart failure
in 9, cerebrovascular events in 13, myocardial infarction
in 5, endocarditis in 12, malignancy in 5, unexpected
Figure 2
Comparison of event-free cumulative survival rates according to the
presence or absence of late significant tricuspid regurgitation.
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causes including sudden death in 3, and unknown in 6.
During the same period, reoperation for isolated severe
TR was performed in 12 patients, among whom 2 died
from right ventricular failure. When cardiovascular death
and reoperation were defined as clinical events, the
probability of event-free survival rate in patients without
late TR was 97.0% ± 1.1% at 100 months, 87.7% ± 2.8% at
140 months, 85.9% ± 2.6% at 160 months, and 85.9% ±
2.6% at 175 months. By comparison, the probability of
event-free survival rate in patients with late TR was
94.4% ± 2.4% at 100 months, 86.2% ± 3.7% at 140 months,
70.9% ± 5.9% at 160 months, and 62.0% ± 9.8% at
175 months. Thus, patients with late TR showed
significantly lower event-free survival rates during follow-
up (P = .03) (Figure 2).
Discussion
In the present study, it was found that the incidence of
late TR was 26.9% after left-sided valve surgery in patients
without preoperative significant TR, and that the
incidence of severe TR was 7.5%. Multivariate logistic
regression analysis revealed the presence of preoperative
atrial fibrillation as the only independent predictor of late
TR development, with an approximately 5-fold elevated
risk. Furthermore, late TR was found to be accompanied
by a lower long-term event-free survival rate. To the best
of our knowledge, this is the largest study to have
evaluated TR late after left-sided valve surgery with a long-
term echocardiographic follow-up.
Clinical significance of late TR
The development of late TR is a common and important
manifestation after left-sided valve surgery and is knownto be linked to exercise intolerance and a poor
prognosis.6,15,16 In particular, moderate and severe TR are
closely coupled with a poor prognosis, even in the
absence of the left ventricular dysfunction or pulmonary
hypertension.15 The reported incidences of TR late after
left-sided valve surgery vary from16% to 67%, according to
study population, the definition of significant TR, and
follow-up duration.5,10–12 Tricuspid regurgitation inci-
dence was found to be 16% by Matsuyama et al11, but the
follow-up duration was relatively short (mean 8.2 years).
In contrast, Porter et al5 reported a much higher
incidence of 67% after amean follow-up of ca 11 years, but
the study population was relatively small. In the present
study, the incidence of late TR development was found to
be ca 27%with a mean follow-up of 11.6 years, and late TR
was found to be closely associated with poor event-free
survival. In our opinion, a follow-up duration of N10 years
is required to detect patients who develop clinically
significant TR late after left-sided valve surgery and to
elucidate its prognostic implications. This is supported by
the results shown in Figure 2, where the discrepancy in
event-free cumulative survival rates was progressively
widened 10 years after left-sided valve surgery.
Mechanism of late TR
Although the underlying mechanism of late TR after
valve surgery is substantially unknown, it is generally
considered “functional” in nature, because the tricuspid
valve is morphologically normal in most patients.
However, in contrast to the wealth of information
available regarding functional mitral regurgitation, little is
available on the mechanism of functional TR. In a
previous study, we demonstrated that right ventricular
geometry and tricuspid annular dilation are closely
associated with functional TR development and
severity.10,17,18 This issue requires further investigation.
Prevention of late TR development
In view of the clinical significance of TR, the identifica-
tion of predictors of late TR is clinically important.
Previous studies have shown that the presence of
preoperative significant TR, the presence of preoperative
atrial fibrillation, an advanced age, or huge left atrium is an
independent predictor of late TR development.5,11,12 In the
present study, we only recruited patients without sig-
nificant preoperative TR to emphasize the de novo
development of significant TR and to remove potential by
residual TR after left-sided valve surgery. As a result, it was
found that only 1 clinical factor, the presence of
preoperative atrial fibrillation, contributed independently
to the occurrence of late TR by multivariate analysis.
As corrective surgery for late TR is associated with high
operative mortality and morbidity,8,9,19 its prevention has
clinically important implications. Currently, tricuspid
annuloplasty is widely performed as a safe and effective
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no generally accepted indications for tricuspid annulo-
plasty have been established. Although preoperative TR
severity and tricuspid annular dimension usually serve as a
guide as to whether tricuspid valve annuloplasty is
indicated,20 tricuspid annuloplasty is adamantly unsuc-
cessful in a substantial number of patients.21
Our findings as is do not provide mechanistic insights
into the determinants of late TR. The association with
atrial fibrillation may be due to the fact that atrial
fibrillation reflects a more advanced underlying valve
disease. However, based on the previous observations on
the impact of chronic atrial fibrillation,22-24 it is likely that
chronic atrial fibrillation induces atrial remodeling and
tricuspid annular dilation which, in turn, develops late
TR. Therefore, it is suggested that tricuspid annuloplasty
should be considered even in patients without significant
TR in the presence of preoperative atrial fibrillation. In
addition, a combined maze operation on top of
tricuspid annuloplasty may provide a solution to the
problem. Previously, we demonstrated that the maze
operation can effectively prevent TR development due to
the restoration and maintenance of atrial mechanical
activity.25 More importantly, careful monitoring for the
development of atrial fibrillation and the timely surgical
correction of underlying left-sided valve disease may help
prevent significant TR development late after surgery and
possibly improve long-term prognosis.
Limitations
Several limitations of the present study need to be
acknowledged. First, this study is limited by its retro-
spective nature. However, the preoperative, operative,
and postoperative findings were prospectively summar-
ized in our database system, which was specifically
designed and maintained throughout the study period.
Second, TR grade was not quantified, but although
quantification may have provided an objective means of
evaluating TR, semi-quantitative TR evaluations were well
validated with angiographic evaluation and clinical
measures of regurgitant severity and thus are widely used
in practice.13,14 Finally, because we excluded 40 patients
who died within 5 years of surgery to focus on the late
development of TR, the event-free survival rates of our
study population were artificially elevated and do not
represent the true postoperative event-free survival.Conclusions
The de novo development of significant TR long after
left-sided valve surgery is not uncommon, with an
estimated incidence of 27%, and is closely associated with
a poor prognosis. The present study identified preopera-
tive atrial fibrillation as the only independent predictor
for the development of late TR. Therefore, tricuspid
annuloplasty should be considered in the presence ofatrial fibrillation, even in patients' mild TR at the time of
surgical correction for left-sided valve disease.References
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